These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 38822647)
21. Neuroprotective effects of ginseng total saponin and ginsenosides Rb1 and Rg1 on spinal cord neurons in vitro. Liao B; Newmark H; Zhou R Exp Neurol; 2002 Feb; 173(2):224-34. PubMed ID: 11822886 [TBL] [Abstract][Full Text] [Related]
22. Neuroprotective effects of ginsenosides. Rausch WD; Liu S; Gille G; Radad K Acta Neurobiol Exp (Wars); 2006; 66(4):369-75. PubMed ID: 17265697 [TBL] [Abstract][Full Text] [Related]
23. Ginsenosides in central nervous system diseases: Pharmacological actions, mechanisms, and therapeutics. Lu J; Wang X; Wu A; Cao Y; Dai X; Liang Y; Li X Phytother Res; 2022 Apr; 36(4):1523-1544. PubMed ID: 35084783 [TBL] [Abstract][Full Text] [Related]
24. Angiomodulatory and neurological effects of ginsenosides. Leung KW; Yung KK; Mak NK; Yue PY; Luo HB; Cheng YK; Fan TP; Yeung HW; Ng TB; Wong RN Curr Med Chem; 2007; 14(12):1371-80. PubMed ID: 17504218 [TBL] [Abstract][Full Text] [Related]
25. Comparative analysis of the neuroprotective effects of ginsenosides Rg1 and Rb1 extracted from Panax notoginseng against cerebral ischemia. Zeng XS; Zhou XS; Luo FC; Jia JJ; Qi L; Yang ZX; Zhang W; Bai J Can J Physiol Pharmacol; 2014 Feb; 92(2):102-8. PubMed ID: 24502632 [TBL] [Abstract][Full Text] [Related]
26. Potential neuroprotective activity of Ginseng in Parkinson's disease: a review. González-Burgos E; Fernandez-Moriano C; Gómez-Serranillos MP J Neuroimmune Pharmacol; 2015 Mar; 10(1):14-29. PubMed ID: 25349145 [TBL] [Abstract][Full Text] [Related]
27. Panax ginseng components and the pathogenesis of Alzheimer's disease (Review). Razgonova MP; Veselov VV; Zakharenko AM; Golokhvast KS; Nosyrev AE; Cravotto G; Tsatsakis A; Spandidos DA Mol Med Rep; 2019 Apr; 19(4):2975-2998. PubMed ID: 30816465 [TBL] [Abstract][Full Text] [Related]
28. Anti-proliferative effects of ginsenosides extracted from mountain ginseng on lung cancer. Lee DG; Jang SI; Kim YR; Yang KE; Yoon SJ; Lee ZW; An HJ; Jang IS; Choi JS; Yoo HS Chin J Integr Med; 2016 May; 22(5):344-52. PubMed ID: 25159864 [TBL] [Abstract][Full Text] [Related]
29. Heat Treatment Enhances the Neuroprotective Effects of Crude Ginseng Saponin by Increasing Minor Ginsenosides. Ji YJ; Kim HD; Lee ES; Jang GY; Seong HA Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108384 [TBL] [Abstract][Full Text] [Related]
30. Oxidative Stress and Ginsenosides: An Update on the Molecular Mechanisms. He B; Chen D; Zhang X; Yang R; Yang Y; Chen P; Shen Z Oxid Med Cell Longev; 2022; 2022():9299574. PubMed ID: 35498130 [TBL] [Abstract][Full Text] [Related]
31. Role of ginsenosides, the main active components of Kim JH; Yi YS; Kim MY; Cho JY J Ginseng Res; 2017 Oct; 41(4):435-443. PubMed ID: 29021688 [No Abstract] [Full Text] [Related]
32. Therapeutic Potential of Ginsenosides as an Adjuvant Treatment for Diabetes. Bai L; Gao J; Wei F; Zhao J; Wang D; Wei J Front Pharmacol; 2018; 9():423. PubMed ID: 29765322 [TBL] [Abstract][Full Text] [Related]
33. Targeting Akt/CREB/BDNF signaling pathway by ginsenosides in neurodegenerative diseases: A mechanistic approach. Zarneshan SN; Fakhri S; Khan H Pharmacol Res; 2022 Mar; 177():106099. PubMed ID: 35092819 [TBL] [Abstract][Full Text] [Related]
34. Diversity of Ginsenoside Profiles Produced by Various Processing Technologies. Piao XM; Huo Y; Kang JP; Mathiyalagan R; Zhang H; Yang DU; Kim M; Yang DC; Kang SC; Wang YP Molecules; 2020 Sep; 25(19):. PubMed ID: 32987784 [TBL] [Abstract][Full Text] [Related]
35. Bioactivity-guided identification and cell signaling technology to delineate the immunomodulatory effects of Panax ginseng on human promonocytic U937 cells. Lee DC; Yang CL; Chik SC; Li JC; Rong JH; Chan GC; Lau AS J Transl Med; 2009 May; 7():34. PubMed ID: 19442267 [TBL] [Abstract][Full Text] [Related]
36. Simultaneous Quantitative Analysis of Ginsenosides Isolated from the Fruit of Kim EN; Kaygusuz O; Lee HS; Jeong GS Molecules; 2021 Apr; 26(7):. PubMed ID: 33917440 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of the adaptogenic potential exerted by ginsenosides Rb1 and Rg1 against oxidative stress-mediated neurotoxicity in an in vitro neuronal model. Fernández-Moriano C; González-Burgos E; Iglesias I; Lozano R; Gómez-Serranillos MP PLoS One; 2017; 12(8):e0182933. PubMed ID: 28813475 [TBL] [Abstract][Full Text] [Related]
38. Ginsenosides and their metabolites: a review of their pharmacological activities in the skin. Lim TG; Lee CC; Dong Z; Lee KW Arch Dermatol Res; 2015 Jul; 307(5):397-403. PubMed ID: 26024573 [TBL] [Abstract][Full Text] [Related]
39. BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides. Choi RJ; Roy A; Jung HJ; Ali MY; Min BS; Park CH; Yokozawa T; Fan TP; Choi JS; Jung HA J Ethnopharmacol; 2016 Aug; 190():219-30. PubMed ID: 27275774 [TBL] [Abstract][Full Text] [Related]
40. A Review of Neuroprotective Effects and Mechanisms of Ginsenosides From Panax Ginseng in Treating Ischemic Stroke. Zhao A; Liu N; Yao M; Zhang Y; Yao Z; Feng Y; Liu J; Zhou G Front Pharmacol; 2022; 13():946752. PubMed ID: 35873557 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]